The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping

Salgia, R; Sattler, M; Scheele, J; Stroh, C; Felip, E

Salgia, R (corresponding author), City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, 1500 East Duarte Rd, Duarte, CA 91010 USA.

CANCER TREATMENT REVIEWS, 2020; 87 ():

Abstract

Dysregulated activation of the MET tyrosine kinase receptor is implicated in the development of solid tumors and can arise through several mechanisms,......

Full Text Link